Provided by Tiger Fintech (Singapore) Pte. Ltd.

Doximity, Inc.

53.21
+0.43000.81%
Post-market: 53.770.5600+1.05%19:56 EDT
Volume:1.94M
Turnover:103.13M
Market Cap:9.98B
PE:53.18
High:53.63
Open:53.00
Low:51.79
Close:52.78
Loading ...

Doximity (DOCS) Q4 Earnings: What To Expect

StockStory
·
05 Feb

Doximity Holds Critical Levels In Sell-Off As Earnings Loom

Blockhead
·
04 Feb

Doximity price target raised to $63 from $57 at BofA

TIPRANKS
·
31 Jan

Revvity (RVTY) Surpasses Q4 Earnings Estimates

Zacks
·
31 Jan

Doximity (DOCS) Receives a Hold from Bank of America Securities

TIPRANKS
·
31 Jan

Dr. Martens Plc Announces Total Voting Rights Update

TIPRANKS
·
31 Jan

Doximity (DOCS) Gains As Market Dips: What You Should Know

Zacks
·
30 Jan

Doximity’s Growth Potential and Valuation Challenges: Hold Rating Amid Conservative Forecasts

TIPRANKS
·
29 Jan

Barclays Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
28 Jan

Goldman Sachs Keeps Their Hold Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
28 Jan

Dr. Martens Reports Q3 Growth and Maintains Positive FY25 Outlook

TIPRANKS
·
27 Jan

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

Zacks
·
23 Jan

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Zacks
·
23 Jan

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

Business Wire
·
17 Jan

Do Doximity's (NYSE:DOCS) Earnings Warrant Your Attention?

Simply Wall St.
·
16 Jan

Dr. Martens Directors Acquire Shares Under Incentive Plan

TIPRANKS
·
16 Jan

Teladoc Partners With Amazon to Expand Chronic Care Program Reach

Zacks
·
15 Jan

Doximity Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
13 Jan

Doximity Is Maintained at Overweight by Keybanc

Dow Jones
·
09 Jan

KeyBanc Cuts Price Target on Doximity to $65 From $70, Keeps Overweight Rating

MT Newswires Live
·
08 Jan